Butalbital / Aspirin / Caffeine
Pronunciation: BYOO-TAL-bih-tuhl/ASS-pihr-in/kaff-EEN
Class: Nonnarcotic analgesic
Trade Names
Fiorinal
- Capsules 325 mg aspirin/40 mg caffeine/50 mg butalbital
Fiortal
- Capsules 325 mg aspirin/40 mg caffeine/50 mg butalbital
Butalbital Compound
- Capsules 325 mg aspirin/40 mg caffeine/50 mg butalbital
- Tablets 325 mg aspirin/40 mg caffeine/50 mg butalbital
Trianal (Canada)
Pharmacology
Butalbital has generalized depressant effect on CNS and, in very high doses, has peripheral effects. Aspirin has analgesic, antipyretic, anti-inflammatory, and antirheumatic effects; its analgesic and anti-inflammatory effects may be mediated through inhibition of prostaglandin synthetase enzyme complex. Aspirin also irreversibly inhibits platelet aggregation. Caffeine is thought to produce constriction of cerebral blood vessels.
Grapefruit and grapefruit juice can react adversely with over 85 prescription medications.
Indications and Usage
Relief of symptom complex of tension (or muscle contraction) headache.
Contraindications
Hypersensitivity to salicylates, aspirin, caffeine, or barbiturates; porphyria; bleeding disorders; syndrome of nasal polyps, angioedema, and bronchospastic reactivity to aspirin or other NSAIDs; peptic ulcer.
Dosage and Administration
Adults and Children 12 yr of age and olderPO 1 to 2 tablets or capsules every 4 h; max, 6 tablets or capsules/day.
Storage/Stability
Store in airtight, light-resistant container at room temperature.
Drug Interactions
Beta-blockers (eg, propranolol), doxycycline, estrogens (including oral contraceptives), felodipine, griseofulvin, nifedipine, phenylbutazone, quinidine, theophyllineEffects of these drugs may be increased.
CorticosteroidsMay enhance renal Cl of aspirin; sudden discontinuation of corticosteroids may result in symptoms of salicylism; effects of corticosteroids may be decreased.
Insulin, oral antidiabetic agentsHypoglycemic effects may be increased.
MAOIsMay increase CNS effects.
Methotrexate, 6-mercaptopurineBone marrow toxicity may occur.
NSAIDsIncreased GI ulceration or bleeding may occur.
Other CNS depressants (eg, ethanol, narcotics, general anesthetics, tranquilizers, sedative-hypnotics)Increased drowsiness, dizziness, and other CNS depressive effects may occur.
Sulfinpyrazone, probenecidUricosuric effects may be decreased.
Tricyclic antidepressantsAntidepressant levels/effect may decrease.
WarfarinAnticoagulant effects may be increased or decreased.
Laboratory Test Interactions
Blood testsSerum amylase; fasting blood glucose; cholesterol; protein; serum hepatic aminotransferase (ALT); uric acid; prothrombin time.
Urine testsGlucose, 5-hydroxyindoleacetic acid; Gerhardt ketone, vanillylmandelic acid; uric acid; diacetic acid; spectrophotometric detection of barbiturates.
Adverse Reactions
Cardiovascular
Tachycardia.
CNS
Drowsiness; dizziness; lightheadedness; confusion; mental depression; unusual excitement; nervousness.
Dermatologic
Rash.
GI
Nausea; vomiting; flatulence; heartburn; abdominal pains; constipation.
Precautions
Pregnancy
Category C .
Lactation
Undetermined.
Children
Safety and efficacy in children younger than 12 yr of age not established.
Renal Function
Use with caution because of decreased elimination.
Hepatic Function
Use with caution because of decreased elimination.
Drug dependency
Prolonged use may produce drug dependency (psychologic and physical) and tolerance.
Peptic ulcer, coagulation abnormalities and preoperative states
Use with extreme caution because of increased bleeding time.
Reye syndrome
May occur in children because of aspirin component; do not use for chickenpox or flu symptoms.
Overdosage
Symptoms
Hyperthermia, tachycardia, respiratory depression, bleeding, drowsiness, confusion, coma, hypotension, hypovolemic shock, nausea, vomiting, tremor, tinnitus, fluid and electrolyte abnormalities, insomnia, restlessness.
Patient Information
- Caution patient that dependency/tolerance may result from long-term use.
- Tell patient to take with food or full glass of water.
- Instruct patient not to discontinue abruptly after long-term regular use.
- Caution patient to avoid intake of alcoholic beverages and other CNS depressants without health care provider approval.
- Warn patient to avoid any hazardous activity (eg, driving, smoking) if dizziness, drowsiness, or decrease in mental acuity occurs.
- Instruct patient to avoid sudden position changes to avoid orthostatic hypotension.
- Advise patient to notify health care provider if any surgical procedures are required. Discontinue aspirin therapy 5 days prior to surgery to reduce potential for bleeding problems.
- Advise patient to report these symptoms to health care provider: persistent or recurrent pain before next scheduled dose, difficulty breathing, buzzing in ears, increased drowsiness, vomiting, abdominal pain, tarry stools, unusual bruising or bleeding.
Copyright © 2009 Wolters Kluwer Health.





